
Tardive Dyskinesia (TD) | AUSTEDO XR® (deutetrabenazine ...
See Prescribing Information, including Boxed Warning. Find information for healthcare professionals about once-daily AUSTEDO XR.
What Medications Cause Tardive Dyskinesia? - Verywell Health
Dec 8, 2025 · Tardive dyskinesia is a side effect that causes uncontrollable, repetitive body movements. It is caused by long-term use of antipsychotic medications.
Tardive Dyskinesia (TD): What It Is, Symptoms & Treatment
Tardive Dyskinesia Tardive dyskinesia is a movement disorder that can develop if you take an antipsychotic medication and/or other types of medications. It’s typically not reversible, but …
Austedo (deutetrabenazine): Uses, Side Effects, Dosage Guide
Aug 20, 2025 · Austedo is used to treat the involuntary movements of Huntington's disease and tardive dyskinesia (TD). Includes Austedo side effects, dosage, uses, interactions, and more
Tardive dyskinesia: Prevention, treatment, and prognosis
Oct 6, 2025 · This page provides information on tardive dyskinesia, including its prevention, treatment options, and prognosis.
Tardive Dyskinesia Cases Undiagnosed Real World Study
2 days ago · A new study shows that tardive dyskinesia is underrecognized in routine care despite clear signs and calls for improved assessment and screening.
Managing Tardive Dyskinesia With VMAT2 Inhibitors in Clinical ...
Jul 28, 2025 · Key Takeaways Tardive dyskinesia results from chronic dopamine-receptor blockade, causing involuntary movements, primarily in the oral-buccal-lingual areas. VMAT2 …
APPROVED USES AUSTEDO XR® (deutetrabenazine) extended-release tablets and AUSTEDO® (deutetrabenazine) tablets are prescription medicines that are used to treat the …
Tardive Dyskinesia Management Risks and Therapeutic Advances
6 days ago · Tardive dyskinesia (TD) is a chronic movement disorder that can appear after long-term treatment with dopamine receptor–blocking agents (DRBAs), especially antipsychotics …
Treatment Strategies for Tardive Dyskinesia - U.S. Pharmacist
May 14, 2025 · US Pharm. 2025;50 (5):HS2-HS5. ABSTRACT: Tardive dyskinesia (TD) is a potentially permanent neurologic disorder that is primarily associated with dopamine receptor …